{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T21:01:07Z","timestamp":1774645267278,"version":"3.50.1"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2012,5,11]],"date-time":"2012-05-11T00:00:00Z","timestamp":1336694400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocrine"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1007\/s12020-012-9690-3","type":"journal-article","created":{"date-parts":[[2012,5,10]],"date-time":"2012-05-10T08:22:35Z","timestamp":1336638155000},"page":"612-615","source":"Crossref","is-referenced-by-count":21,"title":["Evidence of a stabilizing mutation of \u03b2-catenin encoded by CTNNB1 exon 3 in a large series of sporadic parathyroid adenomas"],"prefix":"10.1007","volume":"42","author":[{"given":"Lee F.","family":"Starker","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annabelle","family":"Fonseca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G\u00f6ran","family":"\u00c5kerstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peyman","family":"Bj\u00f6rklund","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gunnar","family":"Westin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tobias","family":"Carling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,5,11]]},"reference":[{"key":"9690_CR1","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1056\/NEJM198001243020402","volume":"302","author":"H Heath 3rd","year":"1980","unstructured":"H. Heath 3rd, S.F. Hodgson, M.A. Kennedy, Primary hyperparathyroidism. Incidence, morbidity, and potential economic impact in a community. N. Engl. J. Med. 302, 189\u2013193 (1980)","journal-title":"N. Engl. J. Med."},{"key":"9690_CR2","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1136\/bmj.317.7162.848","volume":"317","author":"E Lundgren","year":"1998","unstructured":"E. Lundgren, E. Szabo, S. Ljunghall, R. Bergstrom, L. Holmberg, J. Rastad, Population based case-control study of sick leave in postmenopausal women before diagnosis of hyperparathyroidism. BMJ 317, 848\u2013851 (1998)","journal-title":"BMJ"},{"key":"9690_CR3","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1210\/jc.2008-1760","volume":"94","author":"SJ Silverberg","year":"2009","unstructured":"S.J. Silverberg, E.M. Lewiecki, L. Mosekilde, M. Peacock, M.R. Rubin, Presentation of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop. J. Clin. Endocrinol. Metab. 94, 351\u2013365 (2009)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"9690_CR4","first-page":"523","volume":"90","author":"CA Verdonk","year":"1981","unstructured":"C.A. Verdonk, A.J. Edis, Parathyroid \u201cdouble adenomas\u201d: fact of fiction? Surgery 90, 523\u2013526 (1981)","journal-title":"Surgery"},{"key":"9690_CR5","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1002\/cncr.22599","volume":"109","author":"PK Lee","year":"2007","unstructured":"P.K. Lee, S.L. Jarosek, B.A. Virnig, M. Evasovich, T.M. Tuttle, Trends in the incidence and treatment of parathyroid cancer in the United States. Cancer 109, 1736\u20131741 (2007)","journal-title":"Cancer"},{"key":"9690_CR6","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1002\/1097-0142(19851001)56:7<1529::AID-CNCR2820560710>3.0.CO;2-D","volume":"56","author":"LE Tisell","year":"1985","unstructured":"L.E. Tisell, S. Carlsson, M. Fjalling, G. Hansson, S. Lindberg, L.M. Lundberg, A. Oden, Hyperparathyroidism subsequent to neck irradiation risk factors. Cancer 56, 1529\u20131533 (1985)","journal-title":"Cancer"},{"key":"9690_CR7","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1007\/s00268-009-0022-6","volume":"33","author":"G Westin","year":"2009","unstructured":"G. Westin, P. Bjorklund, G. Akerstrom, Molecular genetics of parathyroid disease. World J. Surg. 33, 2224\u20132233 (2009)","journal-title":"World J. Surg."},{"key":"9690_CR8","doi-asserted-by":"crossref","first-page":"2960","DOI":"10.1210\/jc.83.8.2960","volume":"83","author":"T Carling","year":"1998","unstructured":"T. Carling, P. Correa, O. Hessman, J. Hedberg, B. Skogseid, D. Lindberg, J. Rastad, G. Westin, G. Akerstrom, Parathyroid MEN1 gene mutations in relation to clinical characteristics of nonfamilial primary hyperparathyroidism. J. Clin. Endocrinol. Metab. 83, 2960\u20132963 (1998)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"9690_CR9","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1210\/jc.83.8.2627","volume":"83","author":"F Farnebo","year":"1998","unstructured":"F. Farnebo, B.-T. Teh, S. Kyt\u00f6l\u00e4, A. Svensson, C. Phelan, K. Sandelin, N.W. Thompson, A. H\u00f6\u00f6g, G. Weber, L.-O. Farnebo, C. Larsson, Alterations of the MEN1 gene in sporadic parathyroid tumors. J. Clin. Endocrinol. Metab. 83, 2627\u20132630 (1998)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"9690_CR10","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1210\/jcem-69-3-496","volume":"69","author":"A Arnold","year":"1989","unstructured":"A. Arnold, H.G. Kim, Clonal loss of one chromosome 11 in a parathyroid adenoma. J. Clin. Endocrinol. Metab. 69, 496\u2013499 (1989)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"9690_CR11","doi-asserted-by":"crossref","first-page":"5522","DOI":"10.1073\/pnas.96.10.5522","volume":"96","author":"M Shtutman","year":"1999","unstructured":"M. Shtutman, J. Zhurinsky, I. Simcha, C. Albanese, M. D\u2019Amico, R. Pestell, A. Ben-Ze\u2019ev, The cyclin D1 gene is a target of the beta-catenin\/LEF-1 pathway. Proc Natl Acad Sci USA 96, 5522\u20135527 (1999)","journal-title":"Proc Natl Acad Sci USA"},{"key":"9690_CR12","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/1476-4598-7-53","volume":"7","author":"P Bjorklund","year":"2008","unstructured":"P. Bjorklund, D. Lindberg, G. Akerstrom, G. Westin, Stabilizing mutation of CTNNB1\/beta-catenin and protein accumulation analyzed in a large series of parathyroid tumors of Swedish patients. Mol. Cancer 7, 53 (2008)","journal-title":"Mol. Cancer"},{"key":"9690_CR13","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1210\/jc.2006-1197","volume":"92","author":"P Bjorklund","year":"2007","unstructured":"P. Bjorklund, G. Akerstrom, G. Westin, Accumulation of nonphosphorylated beta-catenin and c-myc in primary and uremic secondary hyperparathyroid tumors. J. Clin. Endocrinol. Metab. 92, 338\u2013344 (2007)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"9690_CR14","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.bbrc.2006.11.056","volume":"352","author":"P Bjorklund","year":"2007","unstructured":"P. Bjorklund, G. Akerstrom, G. Westin, Activated beta-catenin in the novel human parathyroid tumor cell line sHPT-1. Biochem. Biophys. Res. Commun. 352, 532\u2013536 (2007)","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"9690_CR15","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1210\/jc.2006-2554","volume":"92","author":"J Costa-Guda","year":"2007","unstructured":"J. Costa-Guda, A. Arnold, Absence of stabilizing mutations of beta-catenin encoded by CTNNB1 exon 3 in a large series of sporadic parathyroid adenomas. J. Clin. Endocrinol. Metab. 92, 1564\u20131566 (2007)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"9690_CR16","first-page":"463","volume":"20","author":"S Ikeda","year":"2002","unstructured":"S. Ikeda, Y. Ishizaki, Y. Shimizu, M. Fujimori, Y. Ojima, M. Okajima, K. Sugino, T. Asahara, Immunohistochemistry of cyclin D1 and beta-catenin, and mutational analysis of exon 3 of beta-catenin gene in parathyroid adenomas. Int. J. Oncol. 20, 463\u2013466 (2002)","journal-title":"Int. J. Oncol."},{"key":"9690_CR17","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1385\/EP:11:3:243","volume":"11","author":"S Semba","year":"2000","unstructured":"S. Semba, R. Kusumi, T. Moriya, H. Sasano, Nuclear accumulation of B-catenin in human endocrine tumors: association with Ki-67 (MIB-1) proliferative activity. Endocr. Pathol. 11, 243\u2013250 (2000)","journal-title":"Endocr. Pathol."},{"key":"9690_CR18","doi-asserted-by":"crossref","first-page":"e328","DOI":"10.1371\/journal.pmed.0040328","volume":"4","author":"P Bjorklund","year":"2007","unstructured":"P. Bjorklund, G. Akerstrom, G. Westin, An LRP5 receptor with internal deletion in hyperparathyroid tumors with implications for deregulated WNT\/beta-catenin signaling. PLoS Med 4, e328 (2007)","journal-title":"PLoS Med"},{"key":"9690_CR19","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1111\/j.1365-2265.2010.03830.x","volume":"73","author":"F Haglund","year":"2010","unstructured":"F. Haglund, A. Andreasson, I.L. Nilsson, A. Hoog, C. Larsson, C.C. Juhlin, Lack of S37A CTNNB1\/beta-catenin mutations in a Swedish cohort of 98 parathyroid adenomas. Clin. Endocrinol. (Oxf) 73, 552\u2013553 (2010)","journal-title":"Clin. Endocrinol. (Oxf)"},{"key":"9690_CR20","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0959-437X(99)80003-3","volume":"9","author":"P Polakis","year":"1999","unstructured":"P. Polakis, The oncogenic activation of beta-catenin. Curr. Opin. Genet. Dev. 9, 15\u201321 (1999)","journal-title":"Curr. Opin. Genet. Dev."},{"key":"9690_CR21","doi-asserted-by":"crossref","unstructured":"V. Guarnieri, F. Baorda, C. Battista, M. Bisceglia, T. Balsamo, E. Gruppioni, M. Fiorentino, L.A. Muscarella, M. Coco, R. Barbano, S. Corbetta, A. Spada, D.E. Cole, L. Canaff, G.N. Hendy, M. Carella, A. Scillitani. A rare S33C mutation of CTNNB1 encoding \u03b2-catenin in a parathyroid adenoma found in an Italian primary hyperparathyroid cohort. Endocrine (2011) doi: 10.1007\/s12020-011-9558-y","DOI":"10.1007\/s12020-011-9558-y"}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-012-9690-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12020-012-9690-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-012-9690-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,24]],"date-time":"2024-04-24T11:43:17Z","timestamp":1713958997000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12020-012-9690-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5,11]]},"references-count":21,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["9690"],"URL":"https:\/\/doi.org\/10.1007\/s12020-012-9690-3","relation":{},"ISSN":["1355-008X","1559-0100"],"issn-type":[{"value":"1355-008X","type":"print"},{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,5,11]]}}}